Search Tag: MRI radiomics

Decision Support

2025 09 Nov

  Hepatocellular carcinoma (HCC) continues to drive significant morbidity and mortality. Microvascular invasion (MVI) is a key marker of aggressive biology, yet confirmation usually arrives only after surgery. An MRI-based approach now captures how uneven the tumour and its immediate surroundings appear on routine sequences, turning those patterns...Read more

IMAGING Management

2025 01 Jul

  Breast cancer, the most prevalent malignancy in women worldwide, is categorised into four molecular subtypes based on receptor expression: luminal A, luminal B, HER2-enriched and triple-negative breast cancer (TNBC). These classifications guide therapeutic decisions and impact prognosis. Conventional methods of determining subtypes rely on biopsy-based...Read more

Women's Health

2025 01 Jul

  Breast cancer, the most prevalent malignancy in women worldwide, is categorised into four molecular subtypes based on receptor expression: luminal A, luminal B, HER2-enriched and triple-negative breast cancer (TNBC). These classifications guide therapeutic decisions and impact prognosis. Conventional methods of determining subtypes rely on biopsy-based...Read more

IMAGING Management

2024 25 Aug

  Breast cancer (BC) remains the most prevalent malignancy among women globally. The classification and accurate identification of human epidermal growth factor receptor 2 (HER2) status are critical for determining appropriate treatment plans, particularly for targeted therapies. Traditionally, HER2 status is assessed through invasive methods such...Read more

IMAGING Management

2024 04 Jul

  Fibrostenosis in Crohn’s disease severely affects patients’ quality of life. Current understanding sees intestinal fibrosis as reversible in its early stages but challenging to treat once it progresses. Medical interventions are effective for mild fibrosis, but moderate to severe cases often require endoscopic or surgical approaches. Accurate...Read more

Artificial Intelligence

2024 04 Jul

  Fibrostenosis in Crohn’s disease severely affects patients’ quality of life. Current understanding sees intestinal fibrosis as reversible in its early stages but challenging to treat once it progresses. Medical interventions are effective for mild fibrosis, but moderate to severe cases often require endoscopic or surgical approaches. Accurate...Read more

IMAGING Management

2024 04 Jul

  Rectal cancer is a prevalent digestive tract tumour and common cancer. The TNM staging system is widely used to predict prognosis and guide adjuvant therapy post-surgery. However, due to tumour heterogeneity, accurate prognostic, diagnostic, and predictive tests are challenging, necessitating the inclusion of additional risk factors for better...Read more

Decision Support

2024 04 Jul

  Rectal cancer is a prevalent digestive tract tumour and common cancer. The TNM staging system is widely used to predict prognosis and guide adjuvant therapy post-surgery. However, due to tumour heterogeneity, accurate prognostic, diagnostic, and predictive tests are challenging, necessitating the inclusion of additional risk factors for better...Read more